Eva I Hyde Selected Research

Therapeutics

1/2010	Testing double mutants of the enzyme nitroreductase for enhanced cell sensitisation to prodrugs: effects of combining beneficial single mutations.
4/2007	Kinetic and structural characterisation of Escherichia coli nitroreductase mutants showing improved efficacy for the prodrug substrate CB1954.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eva I Hyde Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 09/2003
3	Carcinoma (Carcinomatosis) 01/2010 - 09/2003
2	Infections 10/2013 - 04/2005
1	Tuberculosis (Tuberculoses) 10/2013

Drug/Important Bio-Agent (IBA)

5	ProdrugsIBA 01/2022 - 09/2003
4	tretazicarIBA 01/2010 - 09/2003
3	EnzymesIBA 01/2010 - 09/2003
2	NitroreductasesIBA 01/2022 - 09/2003
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 04/2005
1	HydroxylaminesIBA 01/2022
1	HydroquinonesIBA 01/2022
1	QuinonesIBA 01/2022
1	Capsules (Microcapsules)IBA 10/2013
1	GlucansIBA 10/2013
1	SolutionsIBA 10/2013
1	Nitrofurantoin (Macrodantin)FDA LinkGeneric 04/2005
1	Nitrofurazone (Nitrofural)FDA Link 04/2005
1	phosphoramide mustardIBA 11/2004

Therapy/Procedure

2	Therapeutics 01/2010 - 04/2007